Article Information
History
- August 22, 2024.
Article Versions
- Version 1 (November 6, 2023 - 12:19).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Shalom K. Henderson1,2,*,
- Siddharth Ramanan1,
- Karalyn E. Patterson1,2,3,
- Peter Garrard4,
- Nikil Patel4,
- Katie A. Peterson2,
- Ajay Halai1,
- Stefano F. Cappa5,6,
- James B. Rowe1,2,3,† and
- Matthew A. Lambon Ralph1,†
- 1Medical Research Council Cognition and Brain Sciences Unit, University of Cambridge, Cambridge CB2 7EF, UK
- 2Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK
- 3Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
- 4Molecular and Clinical Sciences Research Institute, St George’s, University of London, London SW17 ORE, UK
- 5University Institute for Advanced Studies IUSS, Pavia, Italy
- 6IRCCS Mondino Foundation, Pavia, Italy
- ↵*Correspondence to: Shalom K. Henderson, MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge CB2 7EF UK Shalom.Henderson{at}mrc-cbu.cam.ac.uk
Posted August 22, 2024.
Lexical Markers of Disordered Speech in Primary Progressive Aphasia and ‘Parkinson-plus’ Disorders
